Jose Luis Abad Selected Research

(2R,3Z)- N- (1- hydroxyoctadec- 3- en- 2- yl)pivalamide

6/2012

C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose Luis Abad Research Topics

Disease

4	Neoplasms (Cancer) 06/2022 - 11/2011
2	Inflammation (Inflammations) 12/2018 - 07/2017
1	Adenocarcinoma of Lung 06/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 06/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2011
1	Infections 07/2010

Drug/Important Bio-Agent (IBA)

5	SphingolipidsIBA 06/2022 - 11/2011
4	CeramidesIBA 01/2020 - 06/2012
2	pachastrissamineIBA 06/2022 - 01/2017
2	dihydroceramide desaturaseIBA 01/2017 - 07/2010
2	Acid CeramidaseIBA 06/2012 - 11/2011
1	CytokinesIBA 07/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2017
1	SmokeIBA 07/2017
1	N-caproylsphingosineIBA 06/2012
1	(2R,3Z)- N- (1- hydroxyoctadec- 3- en- 2- yl)pivalamideIBA 06/2012
1	Antineoplastic Agents (Antineoplastics)IBA 05/2012
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2012
1	CeramidasesIBA 11/2011

Therapy/Procedure

1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Intralymphatic Injections 01/2017
1	Therapeutics 05/2012
1	Drug Therapy (Chemotherapy) 11/2011